Table 4.
Kazal sequences predicted to produce the greatest possible Kas
Sequences | Predicted
Ka, M−1
|
||||||
---|---|---|---|---|---|---|---|
CHYM | PPE | CARL | SGPA | SGPB | HLE | ||
P6 P1 P14′P18′ | |||||||
CHYM | QCWCTYEYR… . AN..P | 4.0 × 1017 | 2.3 × 104 | 1.3 × 109 | 6.0 × 1011 | 1.1 × 1010 | 3.2 × 106 |
PPE | TEYCTAEYM… . PN..V | 3.1 × 106 | 5.1 × 1013 | 2.0 × 1010 | 1.3 × 1012 | 8.4 × 1010 | 1.5 × 1010 |
CARL | WDFCYCEWD… . GN..Q | 3.9 × 103 | 8.6 × 106 | 1.2 × 1017 | 5.6 × 109 | 9.6 × 108 | 1.7 × 107 |
SGPA | SYYCTCEYT… . GN..V | 4.4 × 108 | 1.3 × 1011 | 9.7 × 1010 | 8.0 × 1015 | 9.8 × 1013 | 1.3 × 1010 |
SGPB | SDYCTCIYK… . GN..V | 3.2 × 108 | 9.8 × 109 | 1.8 × 1013 | 3.7 × 1014 | 2.8 × 1015 | 6.0 × 108 |
HLE | RLWCTIEYF… . GN..D | 4.6 × 108 | 7.7 × 109 | 1.9 × 106 | 5.9 × 109 | 2.4 × 108 | 2.4 × 1016 |
Based on our SRA, these sequences in a Kazal inhibitor scaffold are predicted to produce greatest possible Kas (in bold) for each enzyme at pH 8.3, 21°C. Only the residues in the consensus contact region (see Fig. 2) are shown. C denotes half cystine, C denotes cysteine.